Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

TriSalus Life Sciences (TLSIW) Treasury Shares (2023 - 2025)

TriSalus Life Sciences' Treasury Shares history spans 3 years, with the latest figure at $1.8 million for Q4 2025.

  • For Q4 2025, Treasury Shares rose 297.65% year-over-year to $1.8 million; the TTM value through Dec 2025 reached $1.8 million, up 297.65%, while the annual FY2025 figure was $1.8 million, 297.65% up from the prior year.
  • Treasury Shares reached $1.8 million in Q4 2025 per TLSIW's latest filing, up from $459357.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $1.8 million in Q4 2025 to a low of $64173.0 in Q4 2023.
  • Average Treasury Shares over 3 years is $783381.0, with a median of $459357.0 recorded in 2024.
  • Peak YoY movement for Treasury Shares: skyrocketed 615.81% in 2024, then surged 297.65% in 2025.
  • A 3-year view of Treasury Shares shows it stood at $64173.0 in 2023, then surged by 615.81% to $459357.0 in 2024, then soared by 297.65% to $1.8 million in 2025.
  • Per Business Quant, the three most recent readings for TLSIW's Treasury Shares are $1.8 million (Q4 2025), $459357.0 (Q4 2024), and $64173.0 (Q4 2023).